Ikarian Capital’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Sell |
58,491
-250,000
| -81% | -$933K | 0.04% | 81 |
|
|
2025
Q1 | $851K | Hold |
308,491
| – | – | 0.1% | 64 |
|
|
2024
Q4 | $1.71M | Sell |
308,491
-6
| -0% | -$33 | 0.23% | 51 |
|
|
2024
Q3 | $2.57M | Sell |
308,497
-150,000
| -33% | -$1.25M | 0.36% | 37 |
|
|
2024
Q2 | $3.12M | Buy |
458,497
+370,000
| +418% | +$2.52M | 0.54% | 30 |
|
|
2024
Q1 | $581K | Sell |
88,497
-76,983
| -47% | -$505K | 0.06% | 67 |
|
|
2023
Q4 | $1.07M | Hold |
165,480
| – | – | 0.1% | 49 |
|
|
2023
Q3 | $832K | Sell |
165,480
-150,000
| -48% | -$755K | 0.1% | 48 |
|
|
2023
Q2 | $2.76M | Sell |
315,480
-405,861
| -56% | -$3.55M | 0.44% | 26 |
|
|
2023
Q1 | $8.54M | Sell |
721,341
-15,978
| -2% | -$189K | 1.94% | 6 |
|
|
2022
Q4 | $7.51M | Sell |
737,319
-166,800
| -18% | -$1.7M | 1.81% | 10 |
|
|
2022
Q3 | $5.33M | Buy |
904,119
+204,119
| +29% | +$1.2M | 1.06% | 14 |
|
|
2022
Q2 | $1.74M | Buy |
+700,000
| New | +$1.74M | 0.32% | 34 |
|